| MPHARM LTD |
| Registered number: |
06871676 |
| Balance Sheet |
| as at 31 March 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Fixed assets |
| Tangible assets |
3 |
|
|
10,802 |
|
|
12,708 |
| Investments |
4 |
|
|
13,500 |
|
|
27,000 |
|
|
|
|
24,302 |
|
|
39,708 |
|
| Current assets |
| Stocks |
|
|
121,480 |
|
|
112,748 |
| Debtors |
5 |
|
277,108 |
|
|
278,222 |
| Prepayments an accrued income |
4,750 |
|
|
- |
| Cash at bank and in hand |
|
|
114,502 |
|
|
61,022 |
|
|
|
517,840 |
|
|
451,992 |
|
| Creditors: amounts falling due within one year |
6 |
|
(249,827) |
|
|
(245,304) |
|
| Net current assets/(liabilities) |
|
|
|
268,013 |
|
|
206,688 |
|
| Total assets less current liabilities |
|
|
|
292,315 |
|
|
246,396 |
|
|
|
|
|
|
|
|
| Creditors: amounts falling due after more than one year |
|
|
|
- |
|
|
(3,178) |
|
| Net assets |
|
|
|
292,315 |
|
|
243,218 |
|
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
6 |
|
|
6 |
| Profit and loss account |
|
|
|
292,309 |
|
|
243,212 |
|
| Shareholders' funds |
|
|
|
292,315 |
|
|
243,218 |
|
|
|
|
|
|
|
|
| The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| Miss F Patel |
| Director |
| Approved by the board on 30 December 2025 |
|
| MPHARM LTD |
| Notes to the Accounts |
| for the year ended 31 March 2025 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
Tangible fixed assets |
|
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows: |
|
|
Plant & machinery |
3 years straight line |
|
Fixtures & Fittings |
15% reducing balance |
|
|
Taxation |
|
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted. |
|
|
Debtors |
|
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts. |
|
|
Creditors |
|
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. |
|
|
Pensions |
|
Contributions to defined contribution plans are expensed in the period to which they relate. |
|
|
Stocks |
|
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised. |
|
|
Provisions |
|
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably. |
|
|
Leased assets |
|
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term. |
|
|
| 2 |
Employees |
2025 |
|
2024 |
| Number |
Number |
|
|
Average number of persons employed by the company |
11 |
|
11 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Tangible fixed assets |
|
|
|
|
Plant and machinery |
|
Motor Vehicles |
|
Total |
| £ |
£ |
£ |
|
Cost |
|
At 1 April 2024 |
27,119 |
|
117,992 |
|
145,111 |
|
At 31 March 2025 |
27,119 |
|
117,992 |
|
145,111 |
|
|
|
|
|
|
|
|
|
|
Depreciation |
|
At 1 April 2024 |
27,119 |
|
105,284 |
|
132,403 |
|
Charge for the year |
- |
|
1,906 |
|
1,906 |
|
At 31 March 2025 |
27,119 |
|
107,190 |
|
134,309 |
|
|
|
|
|
|
|
|
|
|
Net book value |
|
At 31 March 2025 |
- |
|
10,802 |
|
10,802 |
|
At 31 March 2024 |
- |
|
12,708 |
|
12,708 |
|
|
| 4 |
Investments |
|
| Other |
| investments |
| £ |
|
Cost |
|
At 1 April 2024 |
27,000 |
|
Revaluation |
(13,500) |
|
|
At 31 March 2025 |
13,500 |
|
|
| 5 |
Debtors |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade debtors |
277,108 |
|
241,199 |
|
Other debtors |
- |
|
37,023 |
|
|
|
|
|
|
277,108 |
|
278,222 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Creditors: amounts falling due within one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Trade creditors |
166,967 |
|
154,806 |
|
Net wages |
11,398 |
|
- |
|
Taxation and social security |
3,554 |
|
36,177 |
|
Accruals and deferred income |
11,880 |
|
- |
|
Other creditors |
6,000 |
|
54,321 |
|
Director's account |
43,918 |
|
- |
|
Corporation tax |
39,813 |
|
- |
|
VAT |
(33,703) |
|
- |
|
|
|
|
|
|
249,827 |
|
245,304 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Creditors: amounts falling due after more than one year |
2025 |
|
2024 |
| £ |
£ |
|
|
Provisions for liabilities |
- |
|
3,178 |
|
|
|
|
|
|
|
- |
|
3,178 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Profit and loss account |
2025 |
| £ |
|
|
At 1 September 2024 |
243,212 |
|
Profit for the year |
124,225 |
|
Dividends |
(76,000) |
|
|
At 31 August 2025 |
291,437 |
|
|
|
|
|
|
|
|
| 9 |
Dividends |
2025 |
|
2024 |
| £ |
£ |
|
|
Dividends for which the company became liable during the year: |
|
Dividends paid |
76,000 |
|
69,500 |
|
|
|
|
|
|
|
76,000 |
|
69,500 |
|
|
|
|
|
|
|
|
|
| 10 |
Contingent liabilities |
|
|
The company is a member of Schizophrenia Medication LLP and is liable to contribute to the assets of the LLP in the event of a winding-up before 1 March 2026. The maximum liability in relation to this undertaking is expected to be £163,892 (2024: £163,892). The company does not believe that a winding-up of the LLP is probable and has not made provision for the liability at 31st March 2025. |
|
|
|
| 11 |
Controlling party |
|
|
The ultimate controlling parties are the directors' and shareholders' Miss F Patel, Miss Y Dadabhai and Mr S S Chander. |
|
|
| 12 |
Other information |
|
|
MPHARM LTD is a private company limited by shares and incorporated in England. Its registered office is: |
|
29-31 Market Street |
|
Darwen |
|
United Kingdom |
|
BB3 1PS |